
FDA approves first maternal vaccine to prevent RSV, Pfizer's single-dose Abrysvo
Fox News
The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo is made by Pfizer.
The single-dose vaccine is administered via injection from 32 and 36 weeks of gestation. Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
This news followed the FDA’s May announcement of the approval of Abrysvo to prevent LRTD in people 60 years of age and older.
More Related News